PISCATAWAY, N.J. — GenScript®, the world’s leading gene synthesis provider, announced today that it will provide funding and DNA synthesis expertise toward a project at Harvard University to generate the first comprehensive, renewable library of Drosophila recombinant antibodies. Proposed by Norbert Perrimon, PhD, the James Stillman Professor of Developmental Biology at Harvard Medical Schooland a Howard Hughes Medical Institute Investigator, the […]

Early access program to fully automated, cyclic, high-content immunofluorescence-based imaging BERGISCH GLADBACH – Miltenyi Biotec, a global provider of products and services for biomedical research and cellular therapy, introduces its new platform for fully automated, ultrahigh-content imaging at the AACR Annual Meeting 2019 in Atlanta, USA: the MACSima™ Imaging Platform. The MACSima™ Imaging Platform is the latest […]

— Integrated Workflow Combines NanoString’s GeoMx DSP High-Plex RNA Assays and Bio-Techne’s Highly Sensitive RNAscope Imaging Reagent Portfolio — MINNEAPOLIS — Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research […]

The new standard in immune profiling for advancing translational and clinical research of immune-mediated diseases SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the introduction of the Maxpar® Direct™ Immune Profiling System. Setting the new standard in immune profiling, the system […]

AACR 2019 includes over 30 abstracts building on QIAGEN’s Sample to Insight solutions to advance understanding of cancer and commitment to improve outcomes Germantown, Maryland, and Hilden, Germany – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of new solutions designed to advance cancer research as part of its highlights at the […]

TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has released a new HTG EdgeSeq Mouse mRNA Tumor Response Panel available now in the United States and Europe. The HTG EdgeSeq Mouse mRNA Tumor Response Panel is designed for use in mouse oncology models to identify and quantify expression […]

Complete Integrated Solution includes High-Throughput Instrument, Validated Protein & RNA Panels, and Integrated Data Analysis Software SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the commercial availability of the GeoMx™ Digital Spatial Profiler during the American Association of Cancer Research (AACR) conference being held March 29th – […]

GOETTINGEN, Germany and ROYSTON, UK — Sartorius Stedim Biotech (SSB), a leading international partner of the biopharmaceutical industry, is introducing integrated online biomass measurement to its ambr® 15 fermentation and ambr® 250 high throughputsystems for microbial applications. Already well known in the industry for fast tracking microbial screening studies and shortening process development timelines, the ambr® 15 fermentation and ambr® […]

•  Combining piggyBac™ transposon technology with Lonza’s GS Xceed® expression system results in stable CHO pools with high levels of recombinant protein expression •  The GS piggyBac™ system offers benefits for bioprocessing, particularly for challenging low-expressing proteins, helping to generate high-performing pools for material supply •  Ability to insert large amounts of DNA into the host […]

A consortium, consisting of Valitacell, Solentim and Microcoat, has been awarded €2.5million under the highly competitive H2020 Fast Track to Innovation (FTI) initiative, and a further €1million from other sources Solentim and Valitacell announce a total of €3.5m funding to produce an integrated platform to deposit, culture, profile and select optimal cells for the manufacture of life-saving biological medicines. Building […]